+674.0%
MRNA vs NUE
+410.3%
+263.8%
-95.4%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for all.
| Period | Portfolio | NUE | Excess | Alpha |
|---|---|---|---|---|
| 1D | +5.4% | +1.6% | +3.8% | +5.2% |
| 7D | -1.1% | -0.6% | -0.5% | -1.0% |
| 30D | +126.1% | -4.6% | +130.7% | +127.0% |
| 3M | +190.0% | -0.3% | +190.3% | +187.8% |
| 6M | +157.2% | +51.9% | +105.3% | +135.5% |
| YTD | +388.2% | +60.0% | +328.2% | +342.8% |
| 1Y | +467.0% | +82.9% | +384.1% | +401.2% |
| 3Y | +36.1% | +66.0% | -29.9% | +20.4% |
| 5Y | -68.0% | +149.0% | -216.9% | -72.4% |
| All | +674.0% | +410.3% | +263.8% | +714.3% |
Cumulative growth
Daily Returns
Daily percentage return beside NUE.
Daily Out/Under-Performance
Portfolio return minus NUE return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × NUE return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over all: compounded portfolio wealth divided by compounded NUE wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
all analysis · Full analysis span regression · 6 months rolling